Emergence of monoclonal antibody b12-resistant human immunodeficiency virus type 1 variants during natural infection in the absence of humoral or cellular immune pressure

Journal of General Virology

Volumn 91, Issue 5, 2010, Pages 1354-1364

  Bunnik, Evelien M ^a   Van Gils, Marit J ^a   Lobbrecht, Marilie S D ^a   Pisas, Linaida ^a   Nanlohy, Nening M ^b   Van Baarle, Debbie ^b   Van Nuenen, Ad C ^a   Hessell, Ann J ^c   Schuitemaker, Hanneke ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIBODY; EPITOPE; MONOCLONAL ANTIBODY B12;

ARTICLE; BINDING SITE; BLOOD ANALYSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE MUTATION; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SERODIAGNOSIS; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS REPLICATION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; EPITOPES; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MUTATION, MISSENSE; NEUTRALIZATION TESTS; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77951079747     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.017319-0     Document Type: Article

References (51)

1. Beaumont, T., van Nuenen, A., Broersen, S., Blattner, W. A., Lukashov, V. V. & Schuitemaker, H. (2001). Reversal of HIV-1 IIIB towards a neutralization resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course. J Virol 75, 2246-2252. (Pubitemid 32147563)
2. Beaumont, T., Quakkelaar, E., van Nuenen, A., Pantophlet, R. & Schuitemaker, H. (2004). Increased sensitivity to CD4 binding sitedirected neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker. J Virol 78, 5651-5657. (Pubitemid 38661652)
3. Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S. & other authors (2004). Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 78, 13232-13252.
4. Boom, R., Sol, C. J. A., Salimans, M. M. M., Jansen, C. L., Wertheimvan Dillen, P. M. E. & van der Noordaa, J. (1991). Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28, 495-503. (Pubitemid 20078123)
5. Bunnik, E. M., Pisas, L., van Nuenen, A. C. & Schuitemaker, H. (2008). Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J Virol 82, 7932-7941.
6. Bunnik, E. M., van Gils, M. J., Lobbrecht, M. S., Pisas, L., van Nuenen, A. C. & Schuitemaker, H. (2009). Changing sensitivity to broadly neutralizing antibodies b12, 2G12, 2F5, and 4E10 of primary subtype B human immunodeficiency virus type 1 variants in the natural course of infection. Virology 390, 348-355.
7. Burton, D. R. (2002). Antibodies, viruses and vaccines. Nat Rev Immunol 2, 706-713.
8. Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H., Sawyer, L. S. W., Hendry, R. M., Dunlop, N. & other authors (1994). Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027. (Pubitemid 24373715)
9. Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A. & other authors (2004). HIV vaccine design and the neutralizing antibody problem. Nat Immunol 5, 233-236. (Pubitemid 38332116)
10. Chen, B., Vogan, E. M., Gong, H., Skehel, J. J., Wiley, D. C. & Harrison, S. C. (2005). Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433, 834-841. (Pubitemid 40314887)
11. Decker, J. M., Bibollet-Ruche, F., Wei, X., Wang, S., Levy, D. N., Wang, W., Delaporte, E., Peeters, M., Derdeyn, C. A. & other authors (2005). Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J Exp Med 201, 1407-1419.
12. Desrosiers, R. C. (2004). Prospects for an AIDS vaccine. Nat Med 10, 221-223.
13. Duenas-Decamp, M. J., Peters, P., Burton, D. & Clapham, P. R. (2008). Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop. J Virol 82, 5807-5814. (Pubitemid 351822255)
14. Duenas-Decamp, M. J., Peters, P. J., Burton, D. & Clapham, P. R. (2009). Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes. J Virol 83, 2575-2583.
15. Edwards, T. G., Hoffman, T. L., Baribaud, F., Wyss, S., LaBranche, C. C., Romano, J., Adkinson, J., Sharron, M., Hoxie, J. A. & other authors (2001). Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J Virol 75, 5230-5239.
16. Euler, Z., van Gils, M. J., Bunnik, E. M., Phung, P., Schweighardt, B., Wrin, T. & Schuitemaker, H. (2010). Cross-reactive neutralizing humoral immunity does not protect from HIV-1 disease progression. J Infect Dis 201, 981-983.
17. Gray, L., Sterjovski, J., Churchill, M., Ellery, P., Nasr, N., Lewin, S. R., Crowe, S. M., Wesselingh, S. L., Cunningham, A. L. & other authors (2005). Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome. Virology 337, 384-398. (Pubitemid 40799005)
18. Greenhead, P., Hayes, P., Watts, P. S., Laing, K. G., Griffin, G. E. & Shattock, R. J. (2000). Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 74, 5577-5586. (Pubitemid 30346592)
19. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41, 95-98.
20. Hogan, C. M. & Hammer, S. M. (2001). Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics. Ann Intern Med 134, 978-996.
21. Jensen, M. A., Li, F. S., Van 't Wout, A. B., Nickle, D. C., Shriner, D., He, H. X., McLaughlin, S., Shankarappa, R., Margolick, J. B. & other authors (2003). Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol 77, 13376-13388.
22. Kaslow, R. A., Carrington, M., Apple, R., Park, L., Muñoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J. & other authors (1996). Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2, 405-411. (Pubitemid 26193012)
23. Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S. & other authors (2008). Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105, 7552-7557. (Pubitemid 351830056)
24. Koning, F. A., Kwa, D., Boeser-Nunnink, B., Dekker, J., Vingerhoed, J., Hiemstra, H. & Schuitemaker, H. (2003). Decreasing sensitivity to RANTES neutralization of CC chemokine receptor 5-using, nonsyncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection. J Infect Dis 188, 864-872.
25. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J. & Hendrickson, W. A. (1998). Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659. (Pubitemid 28289647)
26. Mo, H., Stamatatos, L., Ip, J. E., Barbas, C. F., Parren, P. W. H. I., Burton, D. R., Moore, J. P. & Ho, D. D. (1997). Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. J Virol 71, 6869-6874. (Pubitemid 27355348)
27. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Ruker, F. & Katinger, H. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 67, 6642-6647. (Pubitemid 23309131)
28. Pantophlet, R., Ollman Saphire, E., Poignard, P., Parren, P. W. H. I., Wilson, I. A. & Burton, D. R. (2003). Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. J Virol 77, 642-658. (Pubitemid 36005001)
29. Peden, K., Emerman, M. & Montagnier, L. (1991). Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 185, 661-672.
30. Peters, P. J., Duenas-Decamp, M. J., Sullivan, W. M., Brown, R., Ankghuambom, C., Luzuriaga, K., Robinson, J., Burton, D. R., Bell, J. & other authors (2008). Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology 5, 5. (Pubitemid 351425955)
31. Petropoulos, C. J., Parkin, N. T., Limoli, K. L., Lie, Y. S., Wrin, T., Huang, W., Tian, H., Smith, D., Winslow, G. A. & other authors (2000). A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother 44, 920-928. (Pubitemid 30165271)
32. Piantadosi, A., Panteleeff, D., Blish, C. A., Baeten, J. M., Jaoko, W., McClelland, R. S. & Overbaugh, J. (2009). HIV-1 neutralizing antibody breadth is affected by factors early in infection, but does not influence disease progression. J Virol 83, 10269-10274.
33. Poignard, P., Sabbe, R., Picchio, G. R., Wang, M., Gulizia, R. J., Katinger, H., Parren, P. W. H. I., Mosier, D. E. & Burton, D. R. (1999). Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity 10, 431-438. (Pubitemid 29205479)
34. Quakkelaar, E. D., Bunnik, E. M., van Alphen, F. P., Boeser-Nunnink, B. D., van Nuenen, A. C. & Schuitemaker, H. (2007a). Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro. Virology 363, 447-453.
35. Quakkelaar, E. D., van Alphen, F. P., Boeser-Nunnink, B. D., van Nuenen, A. C., Pantophlet, R. & Schuitemaker, H. (2007b). Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies. J Virol 81, 8533-8542. (Pubitemid 47242826)
36. Repits, J., Sterjovski, J., Badia-Martinez, D., Mild, M., Gray, L., Churchill, M. J., Purcell, D. F., Karlsson, A., Albert, J. & other authors (2008). Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge. Virology 379, 125-134.
37. Richman, D. D., Wrin, T., Little, S. J. & Petropoulos, C. J. (2003). Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A 100, 4144-4149. (Pubitemid 36418171)
38. Rusert, P., Kuster, H., Joos, B., Misselwitz, B., Gujer, C., Leemann, C., Fischer, M., Stiegler, G., Katinger, H. & other authors (2005). Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors. J Virol 79, 8454-8469.
39. Saphire, E. O., Parren, P. W., Pantophlet, R., Zwick, M. B., Morris, G. M., Rudd, P. M., Dwek, R. A., Stanfield, R. L., Burton, D. R. & other authors (2001). Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design. Science 293, 1155-1159. (Pubitemid 32758099)
40. Schuitemaker, H., Koot, M., Kootstra, N. A., Dercksen, M. W., De Goede, R. E. Y., Van Steenwijk, R. P., Lange, J. M. A., Eeftink Schattenkerk, J. K. M., Miedema, F. & other authors (1992). Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 66, 1354-1360.
41. Schweighardt, B., Liu, Y., Huang, W., Chappey, C., Lie, Y. S., Petropoulos, C. J. & Wrin, T. (2007). Development of an HIV-1 reference panel of subtype B envelope clones isolated from the plasma of recently infected individuals. J Acquir Immune Defic Syndr 46, 1-11. (Pubitemid 47507428)
42. Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F. & Katinger, H. (2001). A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 17, 1757-1765. (Pubitemid 34114213)
43. gag. Virology 171, 149-155.
44. Trkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. P., Katinger, H., Barbas, C. F., III, Burton, D. R. & other authors (1995). Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol 69, 6609-6617.
45. van Gils, M. J., Euler, Z., Schweighardt, B., Wrin, T. & Schuitemaker, H. (2009). Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression. AIDS 23, 2405-2414.
46. van Griensven, G. J. P., de Vroome, E. M. M., Goudsmit, J. & Coutinho, R. A. (1989). Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. BMJ 298, 218-221. (Pubitemid 19045133)
47. Van't Wout, A. B., Kootstra, N. A., Mulder-Kampinga, G. A., Albrechtvan Lent, N., Scherpbier, H. J., Veenstra, J., Boer, K., Coutinho, R. A., Miedema, F. & Schuitemaker, H. (1994). Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 94, 2060-2067.
48. Van't Wout, A. B., Schuitemaker, H. & Kootstra, N. A. (2008). Isolation and propagation of HIV-1 on peripheral blood mononuclear cells. Nat Protoc 3, 363-370.
49. Wu, X., Zhou, T., O'Dell, S., Wyatt, R. T., Kwong, P. D. & Mascola, J. R. (2009). Mechanism of HIV-1 resistance to monoclonal antibody b12 that effectively targets the site of CD4 attachment. J Virol 83, 10892-10907.
50. Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A. & Sodroski, J. (1998). The antigenic structure of the HIV gp120 envelope protein. Nature 393, 705-711. (Pubitemid 28289663)
51. Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S. H., Yang, X., Zhang, M. Y., Zwick, M. B. & other authors (2007). Structural definition of a conserved neutralization epitope onHIV-1 gp120. Nature 445, 732-737. (Pubitemid 46279718)